Teresita Lopez

1.1k total citations
11 papers, 820 citations indexed

About

Teresita Lopez is a scholar working on Oncology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Teresita Lopez has authored 11 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Epidemiology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Teresita Lopez's work include Viral-associated cancers and disorders (10 papers), Cytomegalovirus and herpesvirus research (6 papers) and Lymphoma Diagnosis and Treatment (4 papers). Teresita Lopez is often cited by papers focused on Viral-associated cancers and disorders (10 papers), Cytomegalovirus and herpesvirus research (6 papers) and Lymphoma Diagnosis and Treatment (4 papers). Teresita Lopez collaborates with scholars based in United States, France and Mexico. Teresita Lopez's co-authors include Helen E. Heslop, Adrian P. Gee, Cliona M. Rooney, Malcolm K. Brenner, M. Helen Huls, Catherine M. Bollard, Karin Straathof, Stephen Gottschalk, Barbara Savoldo and Heidi V. Russell and has published in prestigious journals such as Blood, The Journal of Immunology and Frontiers in Immunology.

In The Last Decade

Teresita Lopez

10 papers receiving 809 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teresita Lopez United States 6 672 337 201 179 130 11 820
Massimo Labirio Italy 9 627 0.9× 252 0.7× 219 1.1× 154 0.9× 108 0.8× 9 816
Pauline Crooks Australia 18 578 0.9× 389 1.2× 198 1.0× 350 2.0× 64 0.5× 37 950
Cosimo G. Sciotto United States 7 527 0.8× 195 0.6× 150 0.7× 337 1.9× 34 0.3× 11 826
Renate de Boer Netherlands 16 576 0.9× 654 1.9× 167 0.8× 65 0.4× 199 1.5× 30 1.1k
Maria Andersson‐Anvret Sweden 12 405 0.6× 90 0.3× 128 0.6× 173 1.0× 43 0.3× 19 565
Paola Chabay Argentina 19 892 1.3× 215 0.6× 252 1.3× 633 3.5× 26 0.2× 58 1.0k
Yan‐jun Gan United States 9 1.1k 1.6× 526 1.6× 571 2.8× 307 1.7× 237 1.8× 11 1.4k
W Strober United States 13 152 0.2× 570 1.7× 125 0.6× 51 0.3× 59 0.5× 22 875
R. F. Ambinder United States 13 449 0.7× 121 0.4× 214 1.1× 241 1.3× 30 0.2× 25 670
Sridhar Chaganti United Kingdom 18 617 0.9× 235 0.7× 135 0.7× 433 2.4× 64 0.5× 61 944

Countries citing papers authored by Teresita Lopez

Since Specialization
Citations

This map shows the geographic impact of Teresita Lopez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teresita Lopez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teresita Lopez more than expected).

Fields of papers citing papers by Teresita Lopez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teresita Lopez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teresita Lopez. The network helps show where Teresita Lopez may publish in the future.

Co-authorship network of co-authors of Teresita Lopez

This figure shows the co-authorship network connecting the top 25 collaborators of Teresita Lopez. A scholar is included among the top collaborators of Teresita Lopez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teresita Lopez. Teresita Lopez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ungar, Benjamin, Jesús Gay-Mimbrera, Beatriz Isla-Tejera, et al.. (2025). Unravelling the transcriptomic landscape of primary lymphocytic scarring alopecias: systematic review and meta-analysis. Frontiers in Immunology. 16. 1651019–1651019.
2.
Louis, Chrystal U., Karin Straathof, Catherine M. Bollard, et al.. (2010). Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal Carcinoma. Journal of Immunotherapy. 33(9). 983–990. 160 indexed citations
3.
Louis, Chrystal U., Karin Straathof, Claudia Gerken, et al.. (2008). 244: Treatment of Epstein Barr Virus Positive Nasopharyngeal Carcinoma with Adoptively Transferred Cytotoxic T Lymphocytes. Biology of Blood and Marrow Transplantation. 14(2). 90–90. 1 indexed citations
4.
Bollard, Catherine M., Maja Stanojević, Ann M. Leen, et al.. (2008). Complete Tumor Responses in Lymphoma Patients Who Receive Autologous Cytotoxic T Lymphocytes Targeting EBV Latent Membrane Proteins. Blood. 112(11). 230–230. 1 indexed citations
5.
Savoldo, Barbara, John A. Goss, Lan Zhang, et al.. (2006). Treatment of solid organ transplant recipients with autologous Epstein Barr virus–specific cytotoxic T lymphocytes (CTLs). Blood. 108(9). 2942–2949. 203 indexed citations
6.
Bollard, Catherine M., Elizabeth L. Buza, Helen Huls, et al.. (2006). The clinical use of LMP2-specific cytotoxic T lymphocytes for the treatment of relapsed EBV +ve Hodgkin disease (HD) and non-Hodgkin lymphoma (NHL). Biology of Blood and Marrow Transplantation. 12(2). 1–1. 56 indexed citations
7.
Bollard, Catherine M., Elizabeth L. Buza, Helen Huls, et al.. (2005). The Use of Autologous LMP2-Specific Cytotoxic T Lymphocytes (CTL) for the Treatment of Relapsed EBV-Positive Hodgkin Disease and Non-Hodgkin Lymphoma.. Blood. 106(11). 773–773. 3 indexed citations
8.
Straathof, Karin, Catherine M. Bollard, Uday Popat, et al.. (2004). Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytes. Blood. 105(5). 1898–1904. 266 indexed citations
9.
Bollard, Catherine M., Helen Huls, Karin Straathof, et al.. (2004). LMP2-Cytotoxic T Lymphocyte Therapy for Relapsed EBV Positive Lymphoma.. Blood. 104(11). 3276–3276. 1 indexed citations
10.
Savoldo, Barbara, April Durett, John A. Goss, et al.. (2002). Generation of EBV-Specific CD4+ Cytotoxic T Cells from Virus Naive Individuals. The Journal of Immunology. 168(2). 909–918. 88 indexed citations
11.
Liu, Zhensheng, Barbara Savoldo, Helen Huls, et al.. (2002). Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes for the Prevention and Treatment of EBV-Associated Post-Transplant Lymphomas. Recent results in cancer research. 159. 123–133. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Massimo Labirio Breakdown of academic impact, for papers by Pauline Crooks Breakdown of academic impact, for papers by Cosimo G. Sciotto Breakdown of academic impact, for papers by Renate de Boer Breakdown of academic impact, for papers by Maria Andersson‐Anvret Breakdown of academic impact, for papers by Paola Chabay Breakdown of academic impact, for papers by Yan‐jun Gan Breakdown of academic impact, for papers by W Strober Breakdown of academic impact, for papers by R. F. Ambinder Breakdown of academic impact, for papers by Sridhar Chaganti
Rankless by CCL
2026